PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 4 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,537,000 | -41.4% | 1,835,000 | -4.9% | 0.64% | -50.8% |
| Q1 2017 | $2,624,000 | +205.5% | 1,930,000 | 0.0% | 1.31% | +158.1% |
| Q4 2016 | $859,000 | -81.3% | 1,930,000 | -76.1% | 0.51% | -79.0% |
| Q3 2016 | $4,600,000 | -12.3% | 8,070,000 | -1.6% | 2.41% | -31.3% |
| Q2 2016 | $5,248,000 | -23.9% | 8,200,000 | 0.0% | 3.50% | -18.5% |
| Q1 2016 | $6,892,000 | -16.6% | 8,200,000 | +1.2% | 4.30% | +24.4% |
| Q4 2015 | $8,262,000 | +92.4% | 8,100,000 | +122.5% | 3.45% | +63.5% |
| Q3 2015 | $4,295,000 | -12.1% | 3,640,000 | +45.3% | 2.11% | +8.7% |
| Q2 2015 | $4,885,000 | – | 2,505,000 | – | 1.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 2,500,000 | $1,963,000 | 1.66% |
| Opaleye Management Inc. | 1,930,000 | $2,624,000 | 1.31% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 9,000,000 | $6,953,000 | 0.10% |
| Baker Brothers Advisors | 3,423,000 | $2,543,000 | 0.02% |